tiprankstipranks
Calidi Biotherapeutics (CLDI)
XASE:CLDI
US Market
CLDI
Calidi Biotherapeutics
RESEARCH TOOLSreports
Want to see CLDI full AI Analyst Report?

Calidi Biotherapeutics (CLDI) Income Statement

361 Followers

Calidi Biotherapeutics Income Statement

Last quarter (Q4 2025), Calidi Biotherapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q4, Calidi Biotherapeutics's net income was $-4.06M. See Calidi Biotherapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Mar 25Dec 23Dec 22Dec 21
Total Revenue
$ 0.00$ 0.00$ 0.00$ 45.00K$ 449.00K
Gross Profit
$ -1.65M$ 0.00$ -1.26M$ -229.00K$ 355.00K
Operating Expenses
$ 18.59M$ 21.78M$ 27.74M$ 22.90M$ 10.84M
Depreciation and Amortization
$ 1.65M$ 1.53M$ 1.26M$ 260.00K$ 156.00K
EBITDA
$ -18.59M$ -19.73M$ -24.20M$ -25.00M$ -9.45M
Operating Income
$ -20.24M$ -21.78M$ -28.99M$ -23.13M$ -10.48M
Other Income/Expenses
$ 192.00K$ -419.00K$ -208.00K$ -2.29M$ 13.88M
Pretax Income
$ -20.05M$ -22.20M$ -29.20M$ -25.42M$ 3.40M
Net Income
$ -19.91M$ -22.14M$ -29.22M$ -25.43M$ -10.93M
Per Share Metrics
Basic EPS
$ -5.95$ -35.70$ -207.61$ -358.80$ 14.16
Diluted EPS
$ -5.95$ -35.70$ -207.61$ -358.80$ 14.16
Weighted Average Shares Outstanding
 4.30M 664.41K 140.16K 70.59K 238.63K
Weighted Average Shares Outstanding (Diluted)
 4.30M 664.41K 140.16K 70.59K 238.63K
Currency in USD

Calidi Biotherapeutics Earnings and Revenue History